Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INtegrilin plus STenting to Avoid Myocardial Necrosis Trial
2007-002617-39Phase 4Terminated
- Sponsor
- Fondazione Mediolanum
- Start
- Jul 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis and acute coronary syndrome (ACS) comparing Integrilin pre-procedural arm with Placebo pre-procedural arm (2 arms). Primary endpoint: Post-procedural peak CK-MB ratio above upper limit of normal. Started Jul 2007; status: terminated.
02
Drugs
eptifibatide
03
Conditions
coronary arteriosclerosisacute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2007-002617-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002617-39.